The zebrafish embryo model: unveiling its potential for investigating phage therapy against methicillin-resistant Staphylococcus aureus infection
- 9 July 2024
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 68 (7) , e0056124
Abstract
Staphylococcus aureus is a pathogenic bacterium responsible for a broad spectrum of infections, including cutaneous, respiratory, osteoarticular, and systemic infections. It poses a significant clinical challenge due to its ability to develop antibiotic resistance. This resistance limits therapeutic options, increases the risk of severe complications, and underscores the urgent need for new strategies to address this threat, including the investigation of treatments complementary to antibiotics. The evaluation of novel antimicrobial agents often employs animal models, with the zebrafish embryo model being particularly interesting for studying host-pathogen interactions, establishing itself as a crucial tool in this field. For the first time, this study presents a zebrafish embryo model for the in vivo assessment of bacteriophage efficacy against S. aureus infection. A localized infection was induced by microinjecting either methicillin-resistant S. aureus (MRSA) or methicillin-susceptible S. aureus (MSSA). Subsequent treatments involved administering either bacteriophage, vancomycin (the reference antibiotic for MRSA), or a combination of both via the same route to explore potential synergistic effects. Our findings indicate that the bacteriophage was as effective as vancomycin in enhancing survival rates, whether used alone or in combination. Moreover, bacteriophage treatment appears to be even more effective in reducing the bacterial load in S. aureus -infected embryos post-treatment than the antibiotic. Our study validates the use of the zebrafish embryo model and highlights its potential as a valuable tool in assessing bacteriophage efficacy treatments in vivo .Keywords
This publication has 33 references indexed in Scilit:
- Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translationClinical Microbiology and Infection, 2023
- A membrane-depolarizing toxin substrate of the Staphylococcus aureus type VII secretion system mediates intraspecies competitionProceedings of the National Academy of Sciences, 2020
- Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical reviewMedicinal Research Reviews, 2019
- Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical researchNature Reviews Microbiology, 2019
- Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish modelScientific Reports, 2019
- Methicillin-resistant Staphylococcus aureusNature Reviews Disease Primers, 2018
- Genetic Manipulation of Staphylococcus aureusCurrent Protocols in Microbiology, 2014
- Establishment of Multi-Site Infection Model in Zebrafish Larvae for Studying Staphylococcus aureus Infectious DiseaseJournal of Genetics and Genomics, 2012
- Zebrafish embryos as an alternative to animal experiments—A commentary on the definition of the onset of protected life stages in animal welfare regulationsReproductive Toxicology, 2012
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995